Victoria Wood

1.2k total citations
21 papers, 895 citations indexed

About

Victoria Wood is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Victoria Wood has authored 21 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Physiology. Recurrent topics in Victoria Wood's work include Pluripotent Stem Cells Research (11 papers), CRISPR and Genetic Engineering (9 papers) and Viral-associated cancers and disorders (5 papers). Victoria Wood is often cited by papers focused on Pluripotent Stem Cells Research (11 papers), CRISPR and Genetic Engineering (9 papers) and Viral-associated cancers and disorders (5 papers). Victoria Wood collaborates with scholars based in United Kingdom, United States and Netherlands. Victoria Wood's co-authors include Susan Fotheringham, Omar Khan, Lindsay Stimson, Lawrence S. Young, John D. O’Neil, William O. Dawson, Nicholas B. La Thangue, Francesco Pezzella, Wenbin Wei and N B La Thangue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Cell.

In The Last Decade

Victoria Wood

21 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Wood United Kingdom 11 561 335 175 127 101 21 895
Kaoru Toyama Japan 10 500 0.9× 233 0.7× 153 0.9× 53 0.4× 166 1.6× 34 817
Ran-Yi Liu China 18 487 0.9× 298 0.9× 79 0.5× 130 1.0× 96 1.0× 26 882
Nicholas C. Hsu Taiwan 15 317 0.6× 236 0.7× 61 0.3× 272 2.1× 62 0.6× 28 815
Delphine Ndiaye‐Lobry France 10 852 1.5× 226 0.7× 54 0.3× 219 1.7× 162 1.6× 16 1.2k
Wei‐Yu Lin Taiwan 16 350 0.6× 123 0.4× 111 0.6× 52 0.4× 111 1.1× 44 667
F. Alameda Spain 13 312 0.6× 268 0.8× 66 0.4× 56 0.4× 93 0.9× 28 711
Megan M. O’Meara United States 17 336 0.6× 481 1.4× 255 1.5× 187 1.5× 48 0.5× 34 952
Silvia Pandolfi Italy 14 676 1.2× 361 1.1× 45 0.3× 118 0.9× 81 0.8× 19 870
Jinha Hwang South Korea 13 965 1.7× 330 1.0× 211 1.2× 116 0.9× 252 2.5× 22 1.4k
Andrea Clocchiatti United States 15 511 0.9× 233 0.7× 37 0.2× 121 1.0× 89 0.9× 17 823

Countries citing papers authored by Victoria Wood

Since Specialization
Citations

This map shows the geographic impact of Victoria Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Wood more than expected).

Fields of papers citing papers by Victoria Wood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Wood. The network helps show where Victoria Wood may publish in the future.

Co-authorship network of co-authors of Victoria Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Wood. A scholar is included among the top collaborators of Victoria Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Wood. Victoria Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacquet, Laureen, et al.. (2016). Generation of KCL040 clinical grade human embryonic stem cell line. Stem Cell Research. 16(1). 173–176. 1 indexed citations
2.
Devito, Liani, Laureen Jacquet, Anastasia Petrova, et al.. (2016). Generation of KCL034 clinical grade human embryonic stem cell line. Stem Cell Research. 16(1). 184–188. 3 indexed citations
3.
Devito, Liani, et al.. (2016). Generation of KCL033 clinical grade human embryonic stem cell line. Stem Cell Research. 16(2). 296–299. 1 indexed citations
4.
Devito, Liani, et al.. (2016). Generation of KCL018 research grade human embryonic stem cell line carrying a mutation in the DMPK gene. Stem Cell Research. 16(2). 342–344. 1 indexed citations
5.
Wood, Victoria, et al.. (2016). Generation of KCL035 research grade human embryonic stem cell line carrying a mutation in HBB gene. Stem Cell Research. 16(2). 210–212. 1 indexed citations
6.
Jacquet, Laureen, et al.. (2016). Generation of KCL031 clinical grade human embryonic stem cell line. Stem Cell Research. 16(1). 195–198. 1 indexed citations
7.
Wood, Victoria, et al.. (2015). Generation of KCL038 clinical grade human embryonic stem cell line. Stem Cell Research. 16(1). 137–139. 2 indexed citations
8.
Wood, Victoria, et al.. (2015). Generation of KCL037 clinical grade human embryonic stem cell line. Stem Cell Research. 16(1). 149–151. 1 indexed citations
9.
Cocks, Graham, Sarah Curran, Priya Gami‐Patel, et al.. (2013). The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders. Psychopharmacology. 231(6). 1079–1088. 33 indexed citations
10.
Stephenson, Emma, et al.. (2012). Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product–free environment. Nature Protocols. 7(7). 1366–1381. 45 indexed citations
11.
Ilić, Duško, Emma Stephenson, Victoria Wood, et al.. (2011). Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy. 14(1). 122–128. 49 indexed citations
12.
Owen, Thomas J., John D. O’Neil, William O. Dawson, et al.. (2010). Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors. Molecular Cancer. 9(1). 241–241. 19 indexed citations
13.
Khan, Omar, Susan Fotheringham, Victoria Wood, et al.. (2010). HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proceedings of the National Academy of Sciences. 107(14). 6532–6537. 119 indexed citations
14.
Newton, Christie & Victoria Wood. (2009). Reflections on facilitating an interprofessional problem-based learning module. Journal of Interprofessional Care. 1–4. 2 indexed citations
15.
Fotheringham, Susan, Mirjam T. Epping, Lindsay Stimson, et al.. (2009). Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis. Cancer Cell. 15(1). 57–66. 102 indexed citations
16.
Stimson, Lindsay, Victoria Wood, Omar Khan, Susan Fotheringham, & N B La Thangue. (2009). HDAC inhibitor-based therapies and haematological malignancy. Annals of Oncology. 20(8). 1293–1302. 107 indexed citations
17.
O’Neil, John D., Thomas J. Owen, Victoria Wood, et al.. (2008). Epstein–Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. Journal of General Virology. 89(11). 2833–2842. 107 indexed citations
18.
Flavell, Joanne R., Karl R. N. Baumforth, Victoria Wood, et al.. (2007). Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus–encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood. 111(1). 292–301. 83 indexed citations
19.
Wood, Victoria, et al.. (2007). Epstein–Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways. Oncogene. 26(28). 4135–4147. 104 indexed citations
20.
Khanim, Farhat L., Lyndon Gommersall, Victoria Wood, et al.. (2004). Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene. 23(40). 6712–6725. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026